Residual Risk Justification: What Auditors and Reviewers Expect (ISO 14971 Guide)

ISO Cloud Consulting editorial team
Editorial illustration for the guide: Residual Risk Justification ISO 14971: What Auditors Expect

Residual risk justification under ISO 14971 requires clear evidence that remaining risks are acceptable based on defined criteria, supported by data, risk-benefit analysis where necessary, and full traceability to risk controls. Auditors expect documented rationale—not assumptions—when residual risks are accepted.

If you cannot justify why a risk is acceptable, your risk management file will fail review.


What Residual Risk Actually Means

Residual risk is the risk that remains after all risk control measures have been implemented.

This is not optional. Every medical device has residual risk.

The key requirement is:

You must demonstrate that residual risk is acceptable.

Related:
Fix Risk Management File Gaps


Why Residual Risk Justification Fails

Most failures are not technical—they are logical.

Common failure pattern:

  • Risk is reduced
  • Marked as “acceptable”
  • No justification provided

This is one of the most common audit findings in ISO 14971 reviews.


What Auditors and Reviewers Actually Expect

1. Defined Risk Acceptability Criteria

You must define what “acceptable risk” means before performing risk analysis.

This includes:

  • Risk matrices
  • Severity and probability thresholds

Audit failure: Acceptability criteria defined after the fact.


2. Clear Residual Risk Evaluation

After controls are applied, you must:

  • Reassess the risk
  • Compare it against acceptability criteria

Audit failure: No reassessment after controls.


3. Justification of Acceptability

This is the critical step.

You must explain:

  • Why the remaining risk is acceptable
  • What evidence supports that decision

Weak justification:
“Risk is low and acceptable”

Strong justification:
“Risk reduced to low probability and moderate severity. This falls within defined acceptable region based on risk criteria. No further control is practicable without impacting device performance.”


4. Risk-Benefit Analysis (When Required)

If residual risk is not acceptable, you must:

  • Perform risk-benefit analysis
  • Demonstrate benefits outweigh risks

Audit failure: Skipping this step when required.


5. Traceability

You must show full linkage:

  • Hazard → risk → control → residual risk

Audit failure: Residual risk not linked to controls.


Real Audit Findings on Residual Risk

Finding 1: Residual Risk Marked Acceptable Without Rationale

Fix:

  • Provide written justification
  • Reference risk criteria explicitly

Finding 2: No Risk-Benefit Analysis

Fix:

  • Document benefit of device
  • Compare against residual risk clearly

Finding 3: Inconsistent Risk Decisions

Fix:

  • Apply criteria consistently
  • Standardise evaluation approach

How to Justify Residual Risk Properly

Step 1: Define Acceptability Criteria

  • Before risk analysis
  • Based on standards and regulations

Step 2: Apply Risk Controls

  • Follow hierarchy of controls

Step 3: Reassess Risk

  • Update probability and severity

Step 4: Justify Acceptability

  • Reference criteria
  • Provide rationale

Step 5: Perform Risk-Benefit Analysis (if needed)

  • Document clinical or functional benefits

Residual risk justification must align with:

  • Design controls
  • Verification and validation
  • Product performance

Related:
Fix Design Controls Gaps


How Residual Risk Links to Post-Market Data

Residual risk must be reassessed when:

Template for this step: the complaint handling SOP and PMS plan are in the ISO 13485 Complaint Handling, PMS & Vigilance Kit ($99).

  • Complaints occur
  • CAPAs are raised
  • New data becomes available

This is where many systems fail—they do not close the loop.


Common Mistakes to Avoid

  • Marking risks acceptable without explanation
  • Not defining criteria upfront
  • Ignoring risk-benefit analysis
  • Failing to link to risk controls

These are major audit triggers.


Quick Residual Risk Checklist

  • Is acceptability criteria defined?
  • Is residual risk reassessed?
  • Is justification documented?
  • Is risk-benefit analysis performed where needed?
  • Is traceability complete?

If not, your file is at risk.


When to Get Expert Support

You should take action if:

  • Your risk file is being challenged
  • Residual risk is not clearly justified
  • You are preparing for regulatory submission

Next steps:


Final Thought

Residual risk justification is where your risk management system is truly tested.

You are not just documenting risk—you are defending your decisions.

If those decisions are not clear, consistent, and evidence-based, your file will not pass review.

Free sample

Get free sample pages from the ISO 14971 Risk Management File Kit

Risk management plan pages and the hazard catalogue. Real, unedited pages so you can judge the files before you buy.

You will also get occasional template updates and guidance. Unsubscribe any time. See our privacy policy.

Back to blog

Leave a comment

Frequently asked questions

What is residual risk in medical device risk management?

Residual risk is the risk that remains after all risk control measures have been implemented. Every medical device has some residual risk. The key requirement under ISO 14971 is that the manufacturer demonstrates this remaining risk is acceptable, based on defined criteria and documented rationale rather than assumptions.

When should risk acceptability criteria be defined?

They should be defined before risk analysis begins, including risk matrices and thresholds for severity and probability. Defining acceptability criteria after the fact is a common audit failure, because it suggests the criteria were shaped to fit the results rather than applied consistently.

What makes a residual risk justification strong rather than weak?

A weak justification simply states that a risk is low and acceptable. A strong one explains the reassessed probability and severity, shows the result falls within the predefined acceptable region, references the criteria explicitly, and explains why further control is not practicable. It is supported by evidence and traced back to controls.

When is a risk-benefit analysis needed for residual risk?

When residual risk is not acceptable against the defined criteria, a risk-benefit analysis is required to demonstrate that the device's benefits outweigh the remaining risk. This involves documenting the clinical or functional benefits and comparing them clearly with the residual risk. Skipping this step when required is a common finding.

Online course

ISO 13485:2016 Internal Auditor Course (Online, Certificate of Completion)

Learn this topic properly: short lessons, worksheets with model answers, a 100% pass mark on every lesson quiz and a certificate of completion. Unlimited access for $299.

Templates that do this job

Editable Word and Excel files. Instant download. Licensed for one organization.